Clinical Trial

A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer

Name: A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer — clinical trial record (NCT07669779)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II clinical study evaluating the safety, tolerability, pharmacokinetics and antitumor efficacy of AK146D1 in combination with AK112 or other anticancer therapies in patients with advanced Non-Small Cell Lung Cancer.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-15

Trial Details

NCT Number	NCT07669779
Lead Sponsor	Akeso
Conditions	Advanced Non Small Cell Lung Cancer (NSCLC)
Enrollment	348 participants
Start Date	2026-07-10
Primary Completion	2027-08-30 (estimated)
Study Completion	2029-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-14